Dr. Allison Ramsey, MD
Allergy & Immunology (Allergy Physician)
- Medicare participating
At a glance
- Medical school
- University of Rochester School of Medicine and Dentistry (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 55
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of Rochester School of Medicine and Dentistry
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Allergy Physician primary
NY license 247804 -
Hospitalist Physician
NY license 247804
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Rochester General Hospital Rochester, NY
Medical groups
- Rochester General Hospital (1,182 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 55
- Services billed
- 202
- Patients’ average age
- 66
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 30 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levocetirizine Dihydrochloride Other prescribers in Rochester, NY | 112 |
| Prednisone Other prescribers in Rochester, NY | 68 |
| Azelastine Hcl Other prescribers in Rochester, NY | 53 |
| Montelukast Sodium Other prescribers in Rochester, NY | 41 |
| Ipratropium Bromide Other prescribers in Rochester, NY | 37 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Rochester, NY | 35 |
| Xolair (omalizumab) | 32 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Rochester, NY | 32 |
| Fluticasone Propionate Other prescribers in Rochester, NY | 30 |
| Dupixent Pen (dupilumab) Other prescribers in Rochester, NY | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 138 payments worth $121,203 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $29,314 |
|---|---|
| Genzyme Corporation | $24,367 |
| Novartis Pharmaceuticals Corporation | $23,063 |
| Regeneron Healthcare Solutions, Inc. | $18,617 |
| GlaxoSmithKline, LLC. | $14,093 |
| Csl Behring | $9,037 |
| Pharming Healthcare, Inc. | $2,304 |
| Genentech USA, Inc. | $294 |
| Compensation for services other than consulting (speaking, faculty) | $81,131 |
|---|---|
| Consulting Fee | $23,641 |
| Travel and Lodging | $11,857 |
| Food and Beverage | $4,521 |
| Education | $53.31 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation May 2, 2025 | Consulting Fee | $7,750 |
| Regeneron Healthcare Solutions, Inc. Jul 25, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $7,340 |
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,340 |
| Genzyme Corporation Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,340 |
| Novartis Pharmaceuticals Corporation Aug 15, 2025 | Consulting Fee | $6,550 |
| Regeneron Healthcare Solutions, Inc. Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,942 |
| AstraZeneca Pharmaceuticals LP Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,720 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| AstraZeneca Pharmaceuticals LP Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| AstraZeneca Pharmaceuticals LP Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
All 78 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Dec 10, 2025 | Consulting Fee AIRSUPRA · Respiratory | $1,611 |
| Genzyme Corporation Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $699 |
| AstraZeneca Pharmaceuticals LP Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,720 |
| AstraZeneca Pharmaceuticals LP Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,180 |
| AstraZeneca Pharmaceuticals LP Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $450 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| AstraZeneca Pharmaceuticals LP Nov 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Cooperstown, NY · in-kind Company’s descriptionSpeaker Expenses | $237 |
| Novartis Pharmaceuticals Corporation Nov 7, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Irving, TX | $78.00 |
| Novartis Pharmaceuticals Corporation Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) Rhapsido · Immunology | $3,375 |
| AstraZeneca Pharmaceuticals LP Nov 3, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $537 |
| AstraZeneca Pharmaceuticals LP Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| AstraZeneca Pharmaceuticals LP Oct 24, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to White Sulphur Springs, WV · in-kind Company’s descriptionSpeaker Expenses | $546 |
| AstraZeneca Pharmaceuticals LP Oct 24, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to White Sulphur Springs, WV · in-kind Company’s descriptionSpeaker Expenses | $212 |
| AstraZeneca Pharmaceuticals LP Oct 24, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to White Sulphur Springs, WV · in-kind Company’s descriptionSpeaker Expenses | $185 |
| Csl Behring Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $3,900 |
| Csl Behring Oct 17, 2025 | Travel and Lodging Andembry · Hematology · travel to Buffalo, NY | $106 |
| Novartis Pharmaceuticals Corporation Oct 10, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Irving, TX · in-kind | $196 |
| AstraZeneca Pharmaceuticals LP Oct 8, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Ithaca, NY · in-kind Company’s descriptionSpeaker Expenses | $123 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $125 |
| Amgen Inc. Sep 8, 2025 | Education in-kind | $34.00 |
| Regeneron Healthcare Solutions, Inc. Sep 5, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to SARATOGA SPRINGS, NY · in-kind | $310 |
| GlaxoSmithKline, LLC. Aug 25, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Utica, NY | $183 |
| GlaxoSmithKline, LLC. Aug 25, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Red Bank, NJ | $66.05 |
| GlaxoSmithKline, LLC. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $2,600 |
| Novartis Pharmaceuticals Corporation Aug 21, 2025 | Consulting Fee | $675 |
| Novartis Pharmaceuticals Corporation Aug 15, 2025 | Consulting Fee | $6,550 |
| Novartis Pharmaceuticals Corporation Aug 15, 2025 | Travel and Lodging travel to ATLANTA, GA | $289 |
| Novartis Pharmaceuticals Corporation Aug 15, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $284 |
| Novartis Pharmaceuticals Corporation Aug 15, 2025 | Travel and Lodging travel to ATLANTA, GA · in-kind | $167 |
| Novartis Pharmaceuticals Corporation Aug 15, 2025 | Travel and Lodging travel to ATLANTA, GA · in-kind | $24.00 |
| GlaxoSmithKline, LLC. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $3,900 |
| Novartis Pharmaceuticals Corporation Aug 14, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $293 |
| Genzyme Corporation Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,340 |
| Genzyme Corporation Aug 13, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Pittsburgh, PA | $408 |
| Genzyme Corporation Aug 13, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Pittsburgh, PA · in-kind | $230 |
| Genzyme Corporation Aug 13, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Pittsburgh, PA | $40.50 |
| Csl Behring Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $1,200 |
| GlaxoSmithKline, LLC. Jul 30, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Utica, NY · in-kind | $204 |
| GlaxoSmithKline, LLC. Jul 30, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Utica, NY · in-kind | $30.00 |
| Regeneron Healthcare Solutions, Inc. Jul 25, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $7,340 |
| Regeneron Healthcare Solutions, Inc. Jul 24, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to SARATOGA SPRINGS, NY · in-kind | $45.00 |
| GlaxoSmithKline, LLC. Jul 23, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Red Bank, NJ · in-kind | $1,012 |
| GlaxoSmithKline, LLC. Jul 23, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Red Bank, NJ · in-kind | $230 |
| Csl Behring Jul 11, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $900 |
| Csl Behring Jul 7, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $2,700 |
| AstraZeneca Pharmaceuticals LP Jul 3, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $250 |
| Regeneron Healthcare Solutions, Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,165 |
| AstraZeneca Pharmaceuticals LP Jun 20, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $2,150 |
| Regeneron Healthcare Solutions, Inc. Jun 6, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to SARATOGA SPRINGS, NY · in-kind | $791 |
| Novartis Pharmaceuticals Corporation Jun 5, 2025 | Travel and Lodging travel to EAST HANOVER, NJ · in-kind | $740 |
| Novartis Pharmaceuticals Corporation Jun 5, 2025 | Travel and Lodging travel to EAST HANOVER, NJ · in-kind | $353 |
| Genzyme Corporation May 22, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,495 |
| Pharming Healthcare, Inc. May 21, 2025 | Consulting Fee JOENJA · APDS | $2,300 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Consulting Fee | $7,750 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ | $399 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ · in-kind | $32.00 |
| Novartis Pharmaceuticals Corporation May 1, 2025 | Travel and Lodging travel to Whippany, NJ · in-kind | $428 |
| Novartis Pharmaceuticals Corporation May 1, 2025 | Education in-kind | $19.31 |
| Regeneron Healthcare Solutions, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $2,260 |
| AstraZeneca Pharmaceuticals LP Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,340 |
| Genzyme Corporation Apr 9, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Concord, NH · in-kind | $979 |
| Genzyme Corporation Apr 9, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Concord, NH · in-kind | $664 |
| Genzyme Corporation Apr 9, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Concord, NH · in-kind | $302 |
| Genzyme Corporation Apr 9, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Concord, NH | $28.00 |
| Genzyme Corporation Apr 9, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Concord, NH | $14.64 |
| AstraZeneca Pharmaceuticals LP Mar 29, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Washington, DC · in-kind Company’s descriptionSpeaker Expenses | $497 |
| AstraZeneca Pharmaceuticals LP Mar 29, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Washington, DC · in-kind Company’s descriptionSpeaker Expenses | $479 |
| AstraZeneca Pharmaceuticals LP Mar 29, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Washington, DC · in-kind Company’s descriptionSpeaker Expenses | $44.00 |
| AstraZeneca Pharmaceuticals LP Mar 19, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $537 |
| AstraZeneca Pharmaceuticals LP Mar 15, 2025 | Consulting Fee | $1,611 |
| GlaxoSmithKline, LLC. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $2,600 |
| Genzyme Corporation Mar 13, 2025 | Consulting Fee | $2,070 |
| GlaxoSmithKline, LLC. Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $2,600 |
| GlaxoSmithKline, LLC. Feb 21, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Amherst, NY | $102 |
| Regeneron Healthcare Solutions, Inc. Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,942 |
| Regeneron Healthcare Solutions, Inc. Feb 11, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to GREENFIELD, MA · in-kind | $403 |
| Regeneron Healthcare Solutions, Inc. Feb 11, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to AMHERST, NY · in-kind | $102 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $93,075 in research payments for these studies, mostly to the institutions running them.
- Registry of Asthma Patients Initiating DUPIXENT®
Regeneron Pharmaceuticals, Inc. · Completed · NCT04287621 - A randomized,double blind,multicenter,parallel group,phase IIIb 52 week study evaluating the efficacy and safety of PT027 compared with PT007 administered as needed in participants 12 to under 18 years of age with as…
AstraZeneca UK Limited - Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT06572228 - A prospective, real-world, interventional study to evaluate the effect
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.